Use of lanthanum to accurately quantify insulin-like growth factor binding to proteins on cell surfaces

Journal of Cellular Biochemistry

Volumn 66, Issue 2, 1997, Pages 256-267

  McCusker, Robert H ^a   Clemmons, David R ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Affinity; Des (1 3) IGF I; Fibroblasts; Glioblastoma; GM10; IGF; IGFBP; Kidney epithelial cells; MDBK; Receptor; T98G; Zinc

Indexed keywords

CATION; FORSKOLIN; LANTHANUM; MANGANESE; SELENIUM; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; STRONTIUM; ZINC;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; FIBROBLAST; GLIOBLASTOMA; HUMAN; HUMAN CELL; KIDNEY CELL; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; TUMOR CELL LINE;

CELL LINE; FETUS; FIBROBLASTS; GLIOBLASTOMA; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; LANTHANUM; MEMBRANE PROTEINS; PROTEIN BINDING; RADIOLIGAND ASSAY; TUMOR CELLS, CULTURED; ZINC;

ANIMALIA; BOVINAE;

EID: 0030792035     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19970801)66:2<256::AID-JCB12>3.0.CO;2-F     Document Type: Article

References (40)

1. Arai T, Clarke J, Parker A, Busby W, Nam T, Clemmons DR (1996): Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I in response to heparin. J Biol Chem 271:6099-6106.
2. Ballard FJ, Ross M, Upton FM, Francis GL (1988): Specific binding of insulin-like growth factors 1 and 2 to the type 1 and type 2 receptors respectively. Biochem J 249:721-726.
3. Baxter RC, Williams PF (1983): Reciprocal modulation of insulin and insulin-like growth factor-I receptor affinity by calcium. Biochem Biophys Res Commun 116:62-67.
4. Blat C, Villaudy J, Binoux M (1994): In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J Clin Invest 93:2286-2290.
5. cCusker RH, Clemmons DR (1992): Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP-2): Comparison of its structural and functional properties with IGFBP-1. J Cell Biochem 48:215-226.
6. cCusker RH, Wright G, Clemmons DR (1992): Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J Biol Chem 267:11949-11956.
7. Clemmons DR, Elgin RG, Han VKM, Casella SJ, D'Ercole AJ, Van Wyk JJ (1986): Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulin-like growth factor I. J Clin Invest 77: 1548-1556.
8. Clemmons DR, Han VKM, Elgin RG, D'Ercole AJ (1987): Alterations in the synthesis of a fibroblast surface associated 35 K protein modulates the binding of somatomedin-C/insulin-like growth factor I. Mol Endocrinol 1:339-347.
9. Cohick WS, Clemmons DR (1991): Regulation of insulin-like growth factor binding protein synthesis and secretion in a bovine epithelial cell line. Endocrinology 129: 1347-1354.
10. Cohick WS, Clemmons DR (1993): Regulation of IGFBP secretion and modulation of cell growth in MDBK cells. Growth Regulat 3:20-23.
11. Coleman ME, Etherton TD (1994): Porcine insulin-like growth factor (IGF)-binding protein-3 elicits biphasic effects on IGF-I stimulated DNA synthesis in neonatal porcine skin fibroblasts. Domest Anim Endocrinol 11:299-305.
12. Conover CA (1991): Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: Evidence for processing of cell-bound IGFBP-3. Endocrinology 129:3259-3268.
13. Conover CA (1992): Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3 - Studies of underlying mechanism. Endocrinology 130:3191-3199.
14. Conover CA, Kiefer MC (1993): Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells. J Clin Endocrinol Metab 76:1153-1159.
15. D'Ercole AJ, Underwood LE, Van Wyk JJ, Decedue CJ, Foushee DB (1976): Specificity, topography and ontogeny of the somatomedin C receptor in mammalian tissues. In Pecile A, Muller R (eds): "Growth Hormone and Related Peptides." Amsterdam: Excepta Medica, pp 190-205.
16. DeVroede MA, Tseng LY-H, Katsoyannis PG, Nissley SP, Rechler MM (1986): Modulation of insulinlike growth factor I binding to human fibroblast monolayer cultures by insulinlike growth factor carrier proteins released to the incubation media. J Clin Invest 77:602-613.
17. Elgin RG, Busby WH, Clemmons DR (1987): An insulin-like growth factor binding protein enhances the biogic response to IGF-I. Proc Natl Acad Sci USA 84:3254-3258.
18. Fowlkes JL, Enghild JJ, Suzuki K, Nagase H (1994): Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J Biol Chem 269:25742-25746.
19. Gopinath R, Walton PE, Etherton TD (1989): An acid stable insulin-like growth factor (IGF)-binding protein from pig serum inhibits binding of IGF-I and IGF-II to vascular endothelial cells. J Endocrinol 120:231-236.
20. Han VKM, Lauder JM, D'Ercole AJ (1988): Rat astroglial somatomedin/insulm-like growth factor binding proteins: Characterization and evidence of biologic function. J Neurosci 8:3135-3143.
21. Hodgkinson SC, Napier JR, Spencer GSG, Bass JJ (1994): Glycosaminoglycan binding characteristics of the insulin-like growth factor-binding proteins. J Mol Endocrinol 113:105-112.
22. Holly JMP, Smith CP, Dunger DB, Edge JA, Biddlecombe RA, Williams AJK, Howell R, Chard T, Savage MO, Rees LH, Wass JAH (1989): Levels of the small insulin-like growth factor-binding protein are strongly related to those of insulin in prepubertal and pubertal children but only weakly so after puberty. J Endocrinol 121:383-387.
23. Jones JI, Clemmons DR (1995): Insulin-like growth factors and their binding proteins: Biological actions. Endocrine Rev 16:3-34.
24. Jones JI, Gockerman A, Busby WH, Camacho-Hubner C, Clemmons DR (1993a): Extracellular matrix contains insulin-like growth factor binding protein-5 - Potentiation of the effects of IGF-I. J Cell Biol 121:679-687.
25. Jones JI, Gockerman A, Busby WH, Wright G, Clemmons DR (1993b): Insulin-like growth factor binding protein-1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 90:10553-10557.
26. Kanzaki S, Hilliker S, Baylink DJ, Mohan S (1994): Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases. Endocrinology 134:383-392.
27. Knauer DJ, Smith GL (1980): Inhibition of biologic activity of multiplication stimulating activity by binding to its carrier protein. Proc Natl Acad Sci USA 77:7252-7254.
28. Kull FC, Jacobs S, Su Y, Svoboda ME, Van Wyk JJ, Cuatrecasas P (1983): Monoclonal antibodies to receptors for insulin and somatomedin-C. J Biol Chem 258:6561-6566.
29. Lamson G, Giudice LC, Cohen P, Liu F, Gargosky S, Muller HL, Oh Y, Wilson KF, Hintz RL, Rosenfeld RG (1993): Proteolysis of IGFBP-3 may be a common regulatory mechanism of IGF action in vivo. Growth Regulat 3:91-95.
30. Martin JL, Ballesteros M, Baxter RC (1992): Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta 1 release IGF-binding protein-3 from human fibroblasts by different mechanisms. Endocrinology 131:1703-1710.
31. McCusker RH, Clemmons DR (1992): The insulin-like growth factor binding proteins: Structure and biological functions. In Schofield PN (ed): "The Insulin-Like Growth Factors: Structure and Biological Functions." Oxford: Oxford University Press, pp 110-150.
32. cCusker RH, Camacho-Hubner C, Clemmons DR (1989b): Identification of the types of insulin like growth factor binding proteins that are secreted by muscle cells in vitro. J Biol Chem 264:7795-7800.
33. cCusker RH, Camacho-Hubner C, Bayne ML, Cascieri MA, Clemmons DR (1990): Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: The modulating effect of cell released IGF binding proteins (IGFBPs). J Cell Physiol 144:244-253.
34. cCusker RH, Busby WH, Dehoff MH, Camacho-Hubner C, Clemmons DR (1991): Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins. Endocrinology 129:939-949.
35. Menuelle P, Plas C (1993): Glycogenic effect of insulin, insulin-like growth factors II and I and association to their specific receptors in cultured rat hepatocytes. Endocrine J 1:527-533.
36. Orlowski CC, Chernausek SD, Akeson R (1989): Actions of insulin-like growth factor-I on the B104 neuronal cell line: Effects on cell replication, receptor characteristics, and influence of secreted binding protein on ligand binding. J Cell Physiol 139:469-476.
37. Ritvos O, Ranta T, Jalkanen J, Suikkari AM, Voutilainen R, Bohn H, Rutanen EM (1988): Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Endocrinology 122:2150-2157.
38. Tollefsen SE, Thompson K, Petersen DJ (1987): Separation of the high affinity insulin-like growth factor I receptor from low affinity binding sites by affinity chromatography. J Biol Chem 262:16461-16469.
39. Tonner E, Beattie J, Flint DJ (1995): Production of insulin-like growth factor binding protein (IGFBP), IGFBP-3 protease, and expression of IGF-I receptors by cells of the sheep immune system. Eur J Endocrinol 132:118-122.
40. Van Obberghen-Schilling EE, Rechler MM, Romanus JA, Knight AB, Nissley SP, Humbel RE (1981): Receptors for insulin like growth factor I are defective in fibroblast cultured from a patient with leprechaunism. J Clin Invest 68:1356-1365.